Information Collection: Registration Certificate-In Vitro Testing With Byproduct Material Under General License, 60422-60423 [2017-27407]

Download as PDF 60422 Federal Register / Vol. 82, No. 243 / Wednesday, December 20, 2017 / Notices sradovich on DSK3GMQ082PROD with NOTICES in the Application, and relying on the representations and agreements contained in the Application, the NRC staff has determined that EDF is qualified to hold the ownership interests previously held by AREVA NP SAS, and that the transfers of ownership and operating interests to EDF, described in the Application, are otherwise consistent with applicable provisions of law, regulations, and previous NRC orders. These findings are subject to the conditions set forth below. The NRC staff further finds that: (1) The requested change of control will not be inimical to the common defense and security or to the health and safety of the public; and (2) the change of control will be in accordance with 10 CFR part 51 of the NRC’s environmental regulations, and all applicable requirements have been satisfied. The findings set forth above are supported by the NRC’s Safety Evaluation Report issued with this Order. on the internet the NRC website http:// www.nrc.gov/reading-rm/adams.html. Persons who do not have access to ADAMS, or who encounter problems in accessing the documents located in ADAMS, should contact the NRC PDR reference staff, by telephone, at 1–800–397–4209, 301–415– 4737, or via email, to pdr@nrc.gov. Dated and issued this 14th day of November, 2017. For the Nuclear Regulatory Commission. Marc L. Dapas, Director, Office of Nuclear Material Safety and Safeguards. III Accordingly, pursuant to Sections 161b, 161i, 183, and 184 of the Act; 42 U.S.C. 2201(b), 2201(i), 2233, and 2234; and 10 CFR 70.36 and 110.50, IT IS HEREBY ORDERED that the Application regarding the indirect transfer of control over licenses listed above from AREVA SA to EDF is approved, subject to the following conditions: 1. With respect to the licenses listed above, EDF, as stated in the Application, will abide by all commitments and representations previously made by AREVA, Inc. These include, are not limited to, maintaining decommissioning records and financial assurance, implementing decontamination activities, and eventually decommissioning the site. 2. The commitments/representations made in the Application regarding reporting relationships and authority over safety and security issues and compliance with NRC requirements shall be adhered to and may not be modified without the prior written consent from the Director, Office of Nuclear Material Safety and Safeguards, or his designee. IT IS FURTHER ORDERED that AREVA, Inc. at least one (1) business day before all actions necessary to accomplish the indirect transfer of control are completed shall so inform the Director of the Office of Nuclear Material Safety and Safeguards, in writing. If the necessary supporting actions have not been completed by March 31, 2018, this Order shall become null and void; provided, however, that, upon timely written application and for good cause shown, such completion date may be extended by further Order. This Order is effective on issuance. For further details with respect to this Order, see the initial Application listed in Section II above, and the Safety Evaluation Report supporting this action, which are available for public inspection at the Commission’s Public Document Room (PDR), located at One White Flint North, Public File Area 01–F21, 11555 Rockville Pike (first floor), Rockville, Maryland, and accessible, electronically, through the Agencywide Documents Access and Management System (ADAMS) Public Electronic Reading Room, [NRC–2017–0166] VerDate Sep<11>2014 21:36 Dec 19, 2017 Jkt 244001 [FR Doc. 2017–27436 Filed 12–19–17; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Information Collection: Registration Certificate—In Vitro Testing With Byproduct Material Under General License Nuclear Regulatory Commission. ACTION: Notice of submission to the Office of Management and Budget; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) has recently submitted a request for renewal of an existing collection of information to the Office of Management and Budget (OMB) for review. The information collection is entitled, NRC Form 483, Registration Certificate—‘‘In Vitro Testing With Byproduct Material Under General License.’’ DATES: Submit comments by January 19, 2018. ADDRESSES: Submit comments directly to the OMB reviewer at: Brandon DeBruhl, Desk Officer, Office of Information and Regulatory Affairs (3150–0038), NEOB–10202, Office of Management and Budget, Washington, DC 20503; telephone: 202–395–0710, email: oira_submission@omb.eop.gov. FOR FURTHER INFORMATION CONTACT: David Cullison, NRC Clearance Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: INFOCOLLECTS.Resource@nrc.gov. SUPPLEMENTARY INFORMATION: SUMMARY: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2017– 0166 when contacting the NRC about the availability of information for this action. You may obtain publicly- PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 available information related to this action by any of the following methods: • Federal rulemaking website: Go to http://www.regulations.gov and search for Docket ID NRC–2017–0166. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The supporting statement and the revised NRC Form 483 are available in ADAMS under Accession Nos. ML17348B437 and ML17300B398, respectively. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without charge by contacting the NRC’s Clearance Officer, David Cullison, Office of the Chief Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: INFOCOLLECTS.Resource@nrc.gov. B. Submitting Comments The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC posts all comment submissions at http:// www.regulations.gov as well as entering the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the OMB, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment submissions into ADAMS. Background Under the provisions of the Paperwork Reduction Act of 1995 (44 E:\FR\FM\20DEN1.SGM 20DEN1 sradovich on DSK3GMQ082PROD with NOTICES Federal Register / Vol. 82, No. 243 / Wednesday, December 20, 2017 / Notices U.S.C. Chapter 35), the NRC recently submitted a request for renewal of an existing collection of information to OMB for review entitled, NRC Form 483, ‘‘Registration Certificate—In Vitro Testing With Byproduct Material Under General License.’’ The NRC hereby informs potential respondents that an agency may not conduct or sponsor, and that a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The NRC published a Federal Register notice with a 60-day comment period on this information collection on August 28, 2017 (82 FR 40809). 1. The title of the information collection: NRC Form 483, Registration Certificate—In Vitro Testing With Byproduct Material Under General License. 2. OMB approval number: 3150–0038. 3. Type of submission: Extension. 4. The form number if applicable: NRC Form 483. 5. How often the collection is required or requested: There is a one-time submittal of information to receive a validated copy of the NRC Form 483 with an assigned registration number. In addition, any changes in the information reported on the NRC Form 483 must be reported in writing to the NRC within 30 days after the effective date of the change. 6. Who will be required or asked to respond: Any physician, veterinarian in the practice of veterinary medicine, clinical laboratory, or hospital which desires a general license to receive, acquire, possess, transfer, or use specified units of byproduct material in certain in vitro clinical or laboratory tests. 7. The estimated number of annual responses: 6. 8. The estimated number of annual respondents: 6. 9. An estimate of the total number of hours needed annually to comply with the information collection requirement or request: 1.12 hours. 10. Abstract: Section 31.11 of Title 10 of the Code of Federal Regulations (10 CFR), established a general license authorizing any physician, clinical laboratory, veterinarian in the practice of veterinary medicine, or hospital to possess certain small quantities of byproduct material for in vitro clinical or laboratory test not involving the internal or external administration of the byproduct material or the radiation therefrom to human beings or animals. Possession of byproduct material under 10 CFR 31.11 is not authorized until the physician, clinical laboratory, veterinarian in the practice of veterinary VerDate Sep<11>2014 21:36 Dec 19, 2017 Jkt 244001 medicine, or hospital has filed the NRC Form 483 and received from the Commission a validated copy of the NRC Form 483 with a registration number. The licensee can use the validated copy of the NRC Form 483 to obtain byproduct material from a specifically licensed supplier. The NRC incorporates this information into a database which is used to verify that a general licensee is authorized to receive the byproduct material. Dated at Rockville, Maryland, this 15th day of December, 2017. For the Nuclear Regulatory Commission. David Cullison, NRC Clearance Officer, Office of the Chief Information Officer. [FR Doc. 2017–27407 Filed 12–19–17; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2016–0274] Information Collection: Request for Approval of Official Foreign Travel Nuclear Regulatory Commission. ACTION: Notice of submission to the Office of Management and Budget; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) has recently submitted a request for renewal of an existing collection of information to the Office of Management and Budget (OMB) for review. The information collection is entitled, ‘‘NRC Form 445, ‘‘Request for Approval of Official Foreign Travel.’’ DATES: Submit comments by January 19, 2018. ADDRESSES: Submit comments directly to the OMB reviewer at: Brandon De Bruhl, Desk Officer, Office of Information and Regulatory Affairs (3150–0193), NEOB–10202, Office of Management and Budget, Washington, DC 20503; telephone: 202–395–0710, email: oira_submission@omb.eop.gov. FOR FURTHER INFORMATION CONTACT: David Cullison, NRC Clearance Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: INFOCOLLECTS.Resource@nrc.gov. SUPPLEMENTARY INFORMATION: SUMMARY: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2016– 0274 when contacting the NRC about PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 60423 the availability of information for this action. You may obtain publiclyavailable information related to this action by any of the following methods: • Federal Rulemaking website: Go to http://www.regulations.gov and search for Docket ID NRC–2016–0274. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The supporting statement and Request for Approval of Official Foreign Travel is available in ADAMS under Accession No. ML17320A776. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without charge by contacting the NRC’s Clearance Officer, David Cullison, Office of the Chief Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: INFOCOLLECTS.Resource@nrc.gov. B. Submitting Comments The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC posts all comment submissions at http:// www.regulations.gov as well as entering the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the OMB, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment submissions into ADAMS. E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 82, Number 243 (Wednesday, December 20, 2017)]
[Notices]
[Pages 60422-60423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27407]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2017-0166]


Information Collection: Registration Certificate--In Vitro 
Testing With Byproduct Material Under General License

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of submission to the Office of Management and Budget; 
request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has recently 
submitted a request for renewal of an existing collection of 
information to the Office of Management and Budget (OMB) for review. 
The information collection is entitled, NRC Form 483, Registration 
Certificate--``In Vitro Testing With Byproduct Material Under General 
License.''

DATES: Submit comments by January 19, 2018.

ADDRESSES: Submit comments directly to the OMB reviewer at: Brandon 
DeBruhl, Desk Officer, Office of Information and Regulatory Affairs 
(3150-0038), NEOB-10202, Office of Management and Budget, Washington, 
DC 20503; telephone: 202-395-0710, email: [email protected].

FOR FURTHER INFORMATION CONTACT: David Cullison, NRC Clearance Officer, 
U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001; 
telephone: 301-415-2084; email: [email protected].

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2017-0166 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal rulemaking website: Go to http://www.regulations.gov and search for Docket ID NRC-2017-0166.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. The 
supporting statement and the revised NRC Form 483 are available in 
ADAMS under Accession Nos. ML17348B437 and ML17300B398, respectively.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting the NRC's Clearance Officer, David Cullison, Office of the 
Chief Information Officer, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001; telephone: 301-415-2084; email: 
[email protected].

B. Submitting Comments

    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC posts all comment submissions at http://www.regulations.gov as well as entering the comment submissions into 
ADAMS. The NRC does not routinely edit comment submissions to remove 
identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the OMB, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment submissions into ADAMS.

Background

    Under the provisions of the Paperwork Reduction Act of 1995 (44

[[Page 60423]]

U.S.C. Chapter 35), the NRC recently submitted a request for renewal of 
an existing collection of information to OMB for review entitled, NRC 
Form 483, ``Registration Certificate--In Vitro Testing With Byproduct 
Material Under General License.'' The NRC hereby informs potential 
respondents that an agency may not conduct or sponsor, and that a 
person is not required to respond to, a collection of information 
unless it displays a currently valid OMB control number.
    The NRC published a Federal Register notice with a 60-day comment 
period on this information collection on August 28, 2017 (82 FR 40809).
    1. The title of the information collection: NRC Form 483, 
Registration Certificate--In Vitro Testing With Byproduct Material 
Under General License.
    2. OMB approval number: 3150-0038.
    3. Type of submission: Extension.
    4. The form number if applicable: NRC Form 483.
    5. How often the collection is required or requested: There is a 
one-time submittal of information to receive a validated copy of the 
NRC Form 483 with an assigned registration number. In addition, any 
changes in the information reported on the NRC Form 483 must be 
reported in writing to the NRC within 30 days after the effective date 
of the change.
    6. Who will be required or asked to respond: Any physician, 
veterinarian in the practice of veterinary medicine, clinical 
laboratory, or hospital which desires a general license to receive, 
acquire, possess, transfer, or use specified units of byproduct 
material in certain in vitro clinical or laboratory tests.
    7. The estimated number of annual responses: 6.
    8. The estimated number of annual respondents: 6.
    9. An estimate of the total number of hours needed annually to 
comply with the information collection requirement or request: 1.12 
hours.
    10. Abstract: Section 31.11 of Title 10 of the Code of Federal 
Regulations (10 CFR), established a general license authorizing any 
physician, clinical laboratory, veterinarian in the practice of 
veterinary medicine, or hospital to possess certain small quantities of 
byproduct material for in vitro clinical or laboratory test not 
involving the internal or external administration of the byproduct 
material or the radiation therefrom to human beings or animals. 
Possession of byproduct material under 10 CFR 31.11 is not authorized 
until the physician, clinical laboratory, veterinarian in the practice 
of veterinary medicine, or hospital has filed the NRC Form 483 and 
received from the Commission a validated copy of the NRC Form 483 with 
a registration number. The licensee can use the validated copy of the 
NRC Form 483 to obtain byproduct material from a specifically licensed 
supplier. The NRC incorporates this information into a database which 
is used to verify that a general licensee is authorized to receive the 
byproduct material.

    Dated at Rockville, Maryland, this 15th day of December, 2017.

    For the Nuclear Regulatory Commission.
David Cullison,
NRC Clearance Officer, Office of the Chief Information Officer.
[FR Doc. 2017-27407 Filed 12-19-17; 8:45 am]
 BILLING CODE 7590-01-P